The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Gracell Biotechnologies Inc(NASDAQ:GRCL) 
Gracell Biotechnologies Inc., a clinical-stage biopharmaceutical company, primarily discovers and develops cell therapies for the treatment of cancer in the People's Republic of China. Its lead product candidates include GC012F, a FasTCAR-enabled dual BCMA- and CD19-directed autologous CAR-T product...
Share this website to your friends
Gracell Biotechnologies Days Receivable Outstanding ttm (DSO)
Gracell Biotechnologies Op Cashflow Per Share ttm
Gracell Biotechnologies Free Cashflow Per Share ttm
Gracell Biotechnologies Cash Per Share ttm
Gracell Biotechnologies P/S ratio ttm
Gracell Biotechnologies (GAAP) P/E ratio ttm
Gracell Biotechnologies P/B ratio ttm
No extra charts and metrics for this ticker.